Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results

11h ago, source:

Puma Biotechnology will issue it's 1Q-2024 results after the close on May 2, 2024, and host a conference call to discuss ...

Puma Biotechnology (NASDAQ: PBYI)

1d ago, source: The Motley Fool

Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that ...

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

15d ago, source: Business Wire

Puma Biotechnology reported an inducement award granted to one new hire in March 2024, as required under Nasdaq Listing Rule ...

Puma Biotechnology Inc PBYI

15d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Puma and the Pitfalls of the “Narrow” Exclusive License

23d ago, source: JD Supra

In Puma Biotechnology, Inc. v. AstraZeneca Pharmaceuticals LP, 21-cv-01338-MFK, 2024 WL 1157120 (D. Del. Mar. 18, 2024), the court granted AstraZeneca’s motion to dismiss Puma for lack of ...

Puma Biotechnology: FDA Allows To Proceed With Clinical Development Of Alisertib

29d ago, source: Business Insider

(RTTNews) - Puma Biotechnology, Inc. (PBYI) said it has been notified by the FDA that its Investigational New Drug Application submission has been reviewed, and Puma can proceed with the clinical ...

Puma Biotechnology Inc.

7d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...